https://orcid.org/0000-0001-7365-7685
References
- Lindor NM, Arsenault TM, Solomon H, et al. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72(7):611–615.
- Maitrepierre F, Marzano AV, Lipsker D. A unified concept of acne in the PAPA spectrum disorders. Dermatology. 2020;16:1–8.
- Sardana K, Bajaj S, Bose SK. Successful treatment of PAPA syndrome with minocycline, dapsone, deflazacort and methotrexate: a cost-effective therapy with a 2-year follow-up. Clin Exp Dermatol. 2019;44(5):577–579.
- Zeeli T, Padalon-Brauch G, Ellenbogen E, et al. Pyoderma gangrenosum, acne and ulcerative colitis in a patient with a novel mutation in the PSTPIP1 gene. Clin Exp Dermatol. 2015;40(4):367–372.
- Ursani MA, Appleyard J, Whiteru O. Pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis (PA-PASH) syndrome: an atypical presentation of a rare syndrome. Am J Case Rep. 2016;17:587–591.
- Garzorz N, Papanagiotou V, Atenhan A, et al. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes? J Eur Acad Dermatol Venereol. 2016;30(1):141–143.
- Marzano AV, Trevisan V, Gattorno M, et al. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol. 2013;149(6):762–764.
- Monte Serrano J, de la Fuente Meira S, Cruanes Monferrer J, et al. PAPASH syndrome with MEFV gene mutation. Med Clin (Barc). 2020;S0025–7753(20)30367-5. DOI: 10.1016/j.medcli.2020.03.018.
- Kobayashi S, Fujimoto S. Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol. 2013;17(5):611–614.
- Hara A, Wada T, Sada KE, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis in Japan: a nationwide, prospective cohort study. J Rheumatol. 2018;45(4):521–528.
- McBride JD, Elgart GW. Pyoderma gangrenosum-like facial ulcers in a woman associated with cocaine use and cANCA/anti-PR3+, pANCA/anti-MPO- serology. JAAD Case Rep. 2020;6(9):945–950.
- Genovese G, Tavecchio S, Berti E, et al. Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review. Rheumatol Int. 2018;38(6):1139–1151.
- Ghias AAP, Brine P. Vanishing vasculitis: a case of acute necrotic skin findings without pathologic features of vasculitis from adulterated cocaine. J Community Hosp Intern Med Perspect. 2017;7(5):321–324.
- Wakamatsu K, Mitsuhashi Y, Yamamoto T, et al. Propylthiouracil-induced antineutrophil cytoplasmic antibody positive vasculitis clinically mimicking pyoderma gangrenosum. J Dermatol. 2012;39(8):736–738.
- Schmid MH, Hary C, Marstaller B, et al. Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome. Eur J Dermatol. 1998;8(1):45–47.
- Hod T, Lazarov A, Edelstein E, et al. A huge pyoderma gangrenosum-like lesion as a presenting sign of antiphospholipid antibody syndrome. J Rheumatol. 2009;36(7):1557–1559.
- Choi YJ, Yoo WH. Pyoderma gangrenosum masquerading as an ulcer related to antiphospholipid antibodies in a patient with systemic lupus erythematosus. Lupus. 2018;27(13):2174–2176.
- Figurelli J, Kolsi K, Franchet C, et al. Breast pyoderma gangrenosum: a rare postoperative complication of antiphospholipid antibody syndrome. Breast J. 2019;25(3):498–499.